|
|
|
|
| LEADER |
05242nam a2200757 4500 |
| 001 |
ocn739120274 |
| 003 |
OCoLC |
| 005 |
20170124071105.7 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
110706s2011 nju ob 000 0 eng |
| 010 |
|
|
|z 2011002984
|
| 040 |
|
|
|a DG1
|b eng
|e pn
|c DG1
|d E7B
|d OCLCQ
|d CDX
|d YDXCP
|d N$T
|d OCLCQ
|d OCLCF
|d OCLCA
|d OCLCQ
|d NLGGC
|d OCLCQ
|d EBLCP
|d OCLCQ
|d DEBBG
|d AZK
|d LOA
|d OCLCO
|d OCLCA
|d MERER
|d OCLCO
|d GrThAP
|
| 019 |
|
|
|a 747412453
|a 751680753
|a 758670738
|a 961555913
|a 962625736
|a 966204491
|
| 020 |
|
|
|a 9781118075685
|
| 020 |
|
|
|a 1118075684
|
| 020 |
|
|
|a 9781118075661
|q (e-book)
|
| 020 |
|
|
|a 1118075668
|q (e-book)
|
| 020 |
|
|
|a 0470566663
|q (Cloth)
|
| 020 |
|
|
|a 9780470566664
|q (Cloth)
|
| 020 |
|
|
|z 9780470566664
|q (cloth)
|
| 020 |
|
|
|z 9781118075678
|q (ePub)
|
| 024 |
8 |
|
|a 9786613203854
|
| 029 |
1 |
|
|a AU@
|b 000049163109
|
| 029 |
1 |
|
|a AU@
|b 000053280047
|
| 029 |
1 |
|
|a DKDLA
|b 820120-katalog:000571996
|
| 029 |
1 |
|
|a DKDLA
|b 830060-katalog:10484657
|
| 029 |
1 |
|
|a DKDLA
|b 860900-katalog:10484657
|
| 029 |
1 |
|
|a NZ1
|b 15915613
|
| 029 |
1 |
|
|a DEBBG
|b BV043393313
|
| 035 |
|
|
|a (OCoLC)739120274
|z (OCoLC)747412453
|z (OCoLC)751680753
|z (OCoLC)758670738
|z (OCoLC)961555913
|z (OCoLC)962625736
|z (OCoLC)966204491
|
| 037 |
|
|
|a 10.1002/9781118075685
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
| 050 |
|
4 |
|a QR186.7
|b .D48 2011
|
| 060 |
|
4 |
|a QW 575
|
| 072 |
|
7 |
|a MED
|x 044000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07/98
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Detection and quantification of antibodies to biopharmaceuticals :
|b practical and applied considerations /
|c [edited] by Michael G. Tovey.
|
| 264 |
|
1 |
|a Hoboken, N.J. :
|b Wiley,
|c [2011]
|
| 264 |
|
4 |
|c ©2011
|
| 300 |
|
|
|a 1 online resource (xxiii, 404 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 380 |
|
|
|a Bibliography
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Principals of risk assessment and monitoring of antibody responses to biopharmaceuticals / Eugen Koren, Erik Foehr, and Charles A. O'Neill -- Immunogenicity of therapeutic proteins : a regulatory perspective / Susan Kirshner -- Guidance on immunogenicity assessment of biologically-derived therapeutic proteins : an European perspective / Meenu Wadhwa and Robin Thorpe -- Japanese regulatory perspective on immunogenicity / Takao Hayakawa and Akiko Ishii -- Enzyme immunoassays and radioimmune assays for quantification of anti-TNF biopharmaceuticals and anti-drug antibodies / Klaus Bendtzen and Morten Svenson -- Confirmatory immunogenicity assays / Eric Wakshull and Daniel Coleman -- The use of pharmacodynamics as a surrogate marker for the detection of anti-drug neutralizing antibodies / Florian Deisenhammer -- Cell-based assays for the detection of neutralizing antibodies to interferon beta (IFN-?) and tumor necrosis factor-alpha (TNF-?) inhibitors / Anthony Meager -- Detection of neutralizing antibodies (NABs) to Interferon-beta by real time RT-PCR / Francesca Gilli and Antonio Bertolotto -- Competitive ligand binding assays for the detection of neutralizing antibodies / Bonnie Wu, George R. Gunn III, and Gopi Shankar.
|
| 505 |
0 |
|
|a The use of surface plasmon resonance for the detection and characterization of antibodies / Steven J. Swanson and Daniel Mytych -- Hypersensitivity reactions to biopharmaceuticals : detection and quantification of drug-specific IgE antibodies / Jørgen Dahlstrøm and Lennart Venemalm -- Standardization and validation of immunoassays and biophysical assays for the detection of anti-drug antibodies / Daniel Kramer -- Standardization and validation of cell-based assays for the detection of neutralizing anti-drug antibodies / Deborah Finco-Kent and Amy Grenham -- Standardization of neutralizing antibody unitge by bioassay design : constant antigen and constant antibody methodology / Sidney E. Grossberg, Yoshimi Kawade, and Leslie D. Grossberg -- Cut-points and performance characteristics for anti-drug antibody assays / Viswanath Devanarayan and Michael G. Tovey -- Dilutional linearity for neutralizing antibody assays / David Lansky and Carrie Wager -- Detection of neutralizing antibodies to biopharmaceuticals in the presence of high levels of circulating drug / Arno Kromminga and Michael G. Tovey.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Immunoglobulins
|x Analysis.
|
| 650 |
|
0 |
|a Immunoassay.
|
| 650 |
|
7 |
|a MEDICAL
|x Immunology.
|2 bisacsh
|
| 650 |
|
7 |
|a Immunoassay.
|2 fast
|0 (OCoLC)fst00967921
|
| 650 |
|
7 |
|a Immunoglobulins
|x Analysis.
|2 fast
|0 (OCoLC)fst00967962
|
| 650 |
|
2 |
|a Antibodies, Neutralizing
|x analysis.
|
| 650 |
|
2 |
|a Antibodies, Neutralizing
|x immunology.
|
| 650 |
|
2 |
|a Biological Factors
|x immunology.
|
| 650 |
|
2 |
|a Immunoassay
|x methods.
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Tovey, Michael G.
|
| 710 |
2 |
|
|a Wiley InterScience (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|t Detection and quantification of antibodies to biopharmaceuticals.
|d Hoboken, N.J. : Wiley, ©2011
|w (DLC) 2011002984
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118075685
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
